Blog | Think Bold, Think Scientific, Think Veristat

3 min read

Understanding When to Submit an IND Application to the FDA

An Interview with Kevin Hennegan, Director, North American Regulatory Affairs at Veristat

4 min read

Selecting the Right EDC System for a Clinical Program

Understanding the Various Considerations for EDC Selection

 

3 min read

Regulatory Guidance Monthly Review - October 2019

October 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug,...